Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Progestogen-only hormonal contraceptives are associated with a 20-30% higher risk of breast cancer and the risk is similar in magnitude to that associated with combined hormonal contraceptives, according to new research.
Seventeen new centres will be built across England to ensure that pregnant women who have serious medical problems can access the treatment they need, NHS England has announced.
Pharmacists, GPs, midwives and obstetricians must work harder to ensure pregnant women are able to access safe and effective medicines, new research suggests.
The government has introduced a new scheme which will allow women to access a year’s supply of HRT for the cost of just two single prescription charges (£18.70).
People with an asymptomatic urinary tract infection (UTI) should not be prescribed antibiotics, according to new NICE guidance.
The government has rejected five of the recommendations from the Women and Equalities Committee report on menopause including the recommendation to consult on making menopause a protected characteristic under the Equality Act 2010 and pilot…
The health and social care committee have recently published a new report which evaluates how England’s healthcare system responds to reports about harmful side effects from medicines and medical devices.
Almost a third of patients who are eligible for cervical screening, around 4.6 million, are not taking up invitations for the life-saving test.
Cervical cancer rates in 2020 were 13 per 100,000 women, which is significantly higher than the World Health Organization’s (WHO) target of four per 100,000 women, according to a study published in The Lancet Global Health journal.
Researchers have discovered a strict relationship between hot temperatures and weight loss in heart failure patients, an indicator that their condition is worsening.
The number of people living with type 1 diabetes is expected to double by 2040 to between 13.5 and 17.5 million people, according to a new modelling study published in The Lancet Diabetes and Endocrinology.